Article
Analysis of FAS (CD95) gene mutations in higher-grade transformation of follicle center lymphoma.
Leukemia & lymphoma - 1 Aug 2003
Do Bao, Lossos Izidore S, Thorstenson Yvonne, Oefner Peter J, Levy Ronald
Abstract excerpt
The FAS antigen (CD95/APO-1) is suggested to be a tumor suppressor gene since mice and patients with congenital FAS mutations are prone to B cell lymphomas and somatic FAS mutations are described in hematological and solid tumors. Indeed, mutations of the FAS antigen have been found in 13% of multiple myelomas, 6% of follicle center lymphomas (FCL) and 21% of diffuse large B-cell lymphomas (DLBCL). To assess the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
